Tamoxifen-Containing Eye Drops Successfully Trigger Cre-Mediated Recombination in the Entire Eye

Adv Exp Med Biol. 2016:854:495-500. doi: 10.1007/978-3-319-17121-0_66.

Abstract

Embryonic lethality in mice with targeted gene deletion is a major issue that can be circumvented by using Cre-loxP-based animal models. Various inducible Cre systems are available, e.g. such that are activated following tamoxifen treatment, and allow deletion of a specific target gene at any desired time point during the life span of the animal. In this study, we describe the efficiency of topical tamoxifen administration by eye drops using a Cre- reporter mouse strain (R26R). We report that tamoxifen-responsive CAGGCre-ER (TM) mice show a robust Cre- mediated recombination throughout the entire eye.

Keywords: Cre; Cre-loxP; Eye; Eye drops; Retina; Tamoxifen.

MeSH terms

  • Animals
  • Estrogen Antagonists / pharmacology
  • Eye / drug effects*
  • Eye / metabolism
  • Integrases / genetics
  • Integrases / metabolism*
  • Mice, Inbred C57BL
  • Mice, Transgenic
  • Ophthalmic Solutions / pharmacology
  • Recombination, Genetic / drug effects*
  • Tamoxifen / pharmacology*
  • beta-Galactosidase / metabolism

Substances

  • Estrogen Antagonists
  • Ophthalmic Solutions
  • Tamoxifen
  • Cre recombinase
  • Integrases
  • beta-Galactosidase